Latest News

Corporate Five things for pharma marketers to know: Friday, February 12, 2016

Five things for pharma marketers to know: Friday, February 12, 2016

Aegerion slashes workforce; GSK president says downward pressure on drug prices is here to stay; Novartis acquires European rights to Remicade biosimilar

Pipeline Drugmakers respond to call for Zika vaccine

Drugmakers respond to call for Zika vaccine

Sanofi is the first to announce the launch of a R&D program for Zika as other pharma companies are assessing whether to join the development race.

Commercial Five things for pharma marketers to know: Thursday, February 11, 2016

Five things for pharma marketers to know: Thursday, February 11, 2016

Copaxone sales fall; Mylan to acquire Swedish drugmaker; health insurers report financial losses from ACA plans

Agency Shannon Hartley, former head of Razorfish Health, joins nonprofit

Shannon Hartley, former head of Razorfish Health, joins nonprofit

She is the first chief marketing officer for Shatterproof.

Pipeline With support of FDA committee, Remicade biosimilar edges closer to market

With support of FDA committee, Remicade biosimilar edges closer to market

The FDA is set to announce its decision on the drug in April.

Agency IPO filing reveals Cannes Lions makes $59 million in annual revenue

IPO filing reveals Cannes Lions makes $59 million in annual revenue

Lions Health, launched in 2014, generated $1.9 million in revenue last year.

Legal/Regulatory Five things for pharma marketers to know: Wednesday, February 10, 2016

Five things for pharma marketers to know: Wednesday, February 10, 2016

SEC is investigating Salix Pharmaceuticals; FDA adcomm recommends approval of Remicade biosimilar; Medicare considers payment changes

Campaigns Federal agencies and ad groups join forces for prediabetes campaign

Federal agencies and ad groups join forces for prediabetes campaign

The campaign targets 86 million Americans, 90% of whom aren't aware they have the condition.

Pipeline Five things for pharma marketers to know: Tuesday, February 9, 2016

Five things for pharma marketers to know: Tuesday, February 9, 2016

The FDA to review biosimilar Remicade; lawmaker looks at panelists' ties to painkiller manufacturers; Novartis signs risk-sharing contracts for Entresto

Data/Analytics Startup unveils tools to improve trial reproducibility

Startup unveils tools to improve trial reproducibility

The newly launched tools aim to reduce the time and costs of marketing new drugs by "debugging" the lab environment.